In a nutshell This study compared Cre8 EVO (amphilimus-eluting) stents to Resolute Onyx (zotarolimus-eluting) stents in patients with diabetes and CAD undergoing percutaneous coronary intervention (PCI). The authors concluded that Cre8 EVO stents were similar or better than Resolute Onyx stents in these patients. Some background...
Read More
In a nutshell This study looked at which antiplatelet drug is better in patients who had percutaneous coronary intervention (PCI). It found that patients who had maintenance treatment with clopidogrel (Plavix) were less likely to suffer from a heart attack, bleeding, stroke, or death over the following 24 months compared to those...
Read More
In a nutshell This study was carried out to compare long-term outcomes between polymer-free (PF) stents and durable polymer (DP) drug-eluting stents (DES) in patients with coronary artery disease (CAD). The study found that at 10 years both DES types had similar outcomes. Some background CAD involves blockages in arteries supplying the...
Read MoreIn a nutshell The aim of this study was to compare the safety and effectiveness of 3 different drug-releasing stents for the heart blood vessels (biodegradable stents versus new permanent stents versus older permanent stents) after 10 years. The main finding of the study was that biodegradable and new permanent stents showed similar results and were...
Read More
In a nutshell This paper studied the effect of stopping antiplatelet therapy following stent placement. Some background A stent is a small device placed in blood vessels to allow blood to flow. Stents can be bare-metal (mesh wire) or drug-eluting (releases medication to block scar tissue from forming). After a stent is inserted, patients...
Read More
